Loading clinical trials...
Loading clinical trials...
This is a multicentre, randomised, double-masked, parallel-group, phase IV comparison of Posiformin 2 % eye ointment (active substance: bibrocathol) in the treatment of blepharitis.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ursapharm Arzneimittel GmbH
NCT07166172 · Congenital Diaphragmatic Hernia, Congenital Abnormalities, and more
NCT04603222 · Blepharitis
NCT07023822 · Breast Cancer, Vulvovaginal Signs and Symptoms, and more
NCT07451678 · Blepharitis
NCT03043911 · Signs and Symptoms, Respiratory
Kharkov District Clinical Hospital
Kharkiv
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions